RYAH Group Inc. (CSE: RYAH) Supporting U.S. Changes in Cannabis Research
New cultivators have approved for federally funded studies in the U.S., and 575 DEA-licensed researchers are standing by, ready for the change RYAH's ecosystem of products allows data to be collected from seed to consumption, providing a holistic view of the plant necessary for optimal research RYAH continues to expand its global clinical and distribution network for plant-based medicine and digital patient care The U.S. is putting an end to its 50-year long prohibition on Cannabis Research (https://ibn.fm/YIrkv). New cultivators have now been approved for federally funded studies. With over 575 DEA-licensed researchers across the U.S., the future of cannabis…